Literature DB >> 4116547

Significance of serum complement levels in chronic liver disease.

N D Finlayson, K Krohn, M H Fauconnet, K E Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4116547

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

1.  Differences between plasma and serum complement in patients with chronic liver disease.

Authors:  S Inai; H Kitamura; T Fujita; J Kojima; K Nagaki
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

2.  Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.

Authors:  C Homann; K Varming; K Høgåsen; T E Mollnes; N Graudal; A C Thomsen; P Garred
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 3.  Problems of bacterial infection in patients with liver disease.

Authors:  R J Wyke
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

4.  Neutrophil function in chronic liver disease.

Authors:  A C Campbell; M W Dronfield; P J Toghill; W G Reeves
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

5.  Activation of the classical complement pathway in spontaneous bacterial peritonitis.

Authors:  G Bird; G Senaldi; M Panos; N Rolando; G Alexander; D Vergani; R Williams
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

6.  Pneumatosis intestinalis and necrotizing enterocolitis associated with liver cirrhosis.

Authors:  Y Tameda; M Hamada; T Hamaguchi; K Sugimoto; H Katou; S Nakazawa; K Takase
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

7.  Serum complement in chronic liver disease.

Authors:  B J Potter; A M Trueman; E A Jones
Journal:  Gut       Date:  1973-06       Impact factor: 23.059

8.  Clinical application of a new nephelometric technique to measure complement activation.

Authors:  D Vergani; L Bevis; B A Nasaruddin; G Mieli-Vergani; D E Tee
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

9.  Complement levels in patients with hepatic dysfunction.

Authors:  R T Ellison; C R Horsburgh; J Curd
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

10.  Microbial translocation in chronic liver diseases.

Authors:  Marilia Rita Pinzone; Benedetto Maurizio Celesia; Michele Di Rosa; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Int J Microbiol       Date:  2012-07-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.